Literature DB >> 18992861

Endometrial polyps and associated factors in Danish women aged 36-74 years.

Eva Dreisler1, Soren Stampe Sorensen, Gunnar Lose.   

Abstract

OBJECTIVE: To identify factors associated with endometrial polyps. STUDY
DESIGN: Case-control study of 140 women with endometrial polyps and 367 controls. Information on potentially associated factors was obtained by a validated questionnaire.
RESULTS: In an age-adjusted logistic regression model, the following was positively associated with endometrial polyps: current use of hormone therapy (odds ratio, 2.81; 95% CI, 1.29-6.13) and being overweight (body mass index > 25 kg/m(2)) (odds ratio, 2.06; 95% CI, 1.12-3.79) (postmenopausal women). Negatively associated was use of oral contraceptive pills (odds ratio, 0.20; 95% CI, 0.06-0.66). Histopathology diagnosed benign endometrial polyps (n = 137), polyp with premalignant disease (n = 3), and benign polyp with concomitant complex hyperplasia/endometrial cancer (n = 3).
CONCLUSION: Being overweight and current use of hormone therapy in postmenopausal women were positively associated, whereas the use of oral contraceptive pills was negatively associated with endometrial polyps. Hypertension and cervical polyps were not associated with endometrial polyps. Endometrial polyps were infrequently related to premalignant and malignant disease.

Entities:  

Mesh:

Year:  2008        PMID: 18992861     DOI: 10.1016/j.ajog.2008.08.065

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps.

Authors:  Jianguo Hu; Rui Yuan
Journal:  Med Sci Monit       Date:  2011-08

2.  Prevalence of endometrial polyps coexisting with uterine fibroids and associated factors.

Authors:  Tuğba Kınay; Zehra Öztürk Başarır; Serap Fırtına Tuncer; Funda Akpınar; Fulya Kayıkçıoğlu; Sevgi Koç
Journal:  Turk J Obstet Gynecol       Date:  2016-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.